Cedars-Sinai Experts Available to Discuss Healthy Aging During GSA 2024 - Report - MDSpire
Advertisement
Cedars-Sinai Experts Available to Discuss Healthy Aging During GSA 2024
Experts on healthy aging from Cedars-Sinai’s growing Center for Translational Geroscience and Geriatrics Program will present their latest research and clinical advances at The Gerontological Society of America’s (GSA) 2024 Annual Scientific Meeting in Seattle, Nov. 13-16.
Clinical Report: Cedars-Sinai Experts Available to Discuss Healthy Aging During GSA 2024
Overview
Cedars-Sinai will present significant advancements in healthy aging research at the GSA 2024 Annual Meeting. Key topics include geroscience, interventions for loneliness, and the management of chronic diseases in older adults.
Background
As the population of older adults in the U.S. continues to grow, understanding healthy aging becomes increasingly critical. Research in geroscience aims to address the biological mechanisms of aging and improve the quality of life for older adults. Cedars-Sinai's initiatives reflect a commitment to evidence-based care tailored to the unique needs of this demographic.
Data Highlights
No specific numerical data or trial results were provided in the source material.
Key Findings
Cedars-Sinai's Center for Translational Geroscience focuses on advancing research in aging biology.
Dr. Sara Espinoza will present on effective recruitment strategies for older adults in clinical research.
The LEAP program, developed by Dr. Allison Moser Mays, effectively reduces loneliness and fear of falling in older adults.
Cedars-Sinai has been recognized as an Age-Friendly Health System, emphasizing patient-centered care.
Research on tau proteins suggests a link between midlife physical activity and reduced dementia risk.
Innovative strategies are being developed to address social determinants of health in older adults.
Clinical Implications
Healthcare providers should consider integrating evidence-based programs like LEAP to address social isolation among older adults. Additionally, understanding the biological aspects of aging can inform clinical practices aimed at improving health outcomes in this population.
Conclusion
Cedars-Sinai's participation in GSA 2024 highlights its leadership in geriatric research and commitment to enhancing the health and well-being of older adults. Continued focus on innovative care models is essential as the aging population grows.